This webinar introduces key updates in acute ischemic stroke management, focusing on how modern decision‑making integrates time‑sensitive evaluation, advanced imaging, and AI‑supported tools. It also reviews the expanded…
Daniel R. Schimmel, MD, explains how balloon pulmonary angioplasty (BPA) uses balloons and specialized catheters to open narrowed vessels in the lungs to improve circulation and reduce symptoms…
An interview with Adam Bosworth, founder of Keas. Keas is a web-based patient resource whose mission is to help patients understand what their health data means and how…
NEW YORK (Reuters Health) – Old age has a greater impact on abdominal surgery outcomes than previously reported, according to two papers in the December Archives of Surgery.…
NEW YORK (Reuters Health) – In patients with chronic total coronary occlusions, drug-eluting stents (DES) have better long-term outcomes than bare metal stents, according to a paper from…
Donnica Moore, MD, President, Sapphire Women’s Health Group, discusses Chronic Fatigue Syndrome or CFS, its definition and symptoms. CFS is a chronic, debilitating neuroimmune disease that not only…
NEW YORK (Reuters Health) – Patients treated with high-dose recombinant activated factor VII (rFVIIa) for spontaneous intracerebral hemorrhage face a “small increased risk of what are usually minor…
NEW YORK (Reuters Health) – The benefits of statins are variable and depend on the agent being taken, a meta-analysis has shown. Pooled data from 10 randomized trials…
NEW YORK (Reuters Health) – Consistent with their ability to block platelet aggregation, selective serotonin reuptake inhibitors (SSRIs) appear to increase the risk of serious upper gastrointestinal (GI)…
Derek Enlander MD, Internist and CFS & Fibromyalgia specialist, discusses Chronic Fatigue Syndrome or ME and its history, symptomatology and diagnosis. Dr. Enlander is the author of the…
NEW YORK (Reuters Health) – In patients with chronic hepatitis B virus (HBV) infection who are hepatitis B e antigen-positive, viral genotype is one of the strongest predictors…
NEW YORK (Reuters Health) – A six-month course of triple antiplatelet therapy after drug-eluting stent implantation reduces the risk of revascularization for up to two years, according to…
